2750. Pseudomonas aeruginosa infections treated with cefiderocol: associations of site of infection and time to first dose with outcomes in PROVE (Retrospective Cefiderocol Chart Review) Study

BACKGROUND: Gram-negative (GN) bacterial resistance is a major global health problem. Cefiderocol (CFDC) is active against Pseudomonas aeruginosa (PA). PROVE is an international, retrospective study of CFDC use in Gram-negative infections (GNI). This analysis examines outcomes by infection site and...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcella, Stephen, Cai, Bin, Friedman, Bruce, Verardi, Stefano, Gozalo, Laurence, Slover, Christine M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678517/
http://dx.doi.org/10.1093/ofid/ofad500.2361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678517/
http://dx.doi.org/10.1093/ofid/ofad500.2361

Ejemplares similares